Literature DB >> 17308101

TSC1 sets the rate of ribosome export and protein synthesis through nucleophosmin translation.

Corey L Pelletier1, Leonard B Maggi, Suzanne N Brady, Danielle K Scheidenhelm, David H Gutmann, Jason D Weber.   

Abstract

Nucleophosmin (B23) is a nucleolar phosphoprotein that has been implicated in numerous cellular processes. In particular, nucleophosmin interacts with nucleolar components of newly synthesized ribosomes to promote ribosome nuclear export. Nucleophosmin is a classic mitogen-induced protein, with changes in its expression correlating with growth factor stimulation. In this study, we examined the underlying mechanism of nucleophosmin induction and showed that hyperproliferative signals emanating from oncogenic H-Ras(V12) cause tremendous increases in nucleophosmin protein expression. Nucleophosmin protein accumulation was dependent on mammalian target of rapamycin (mTOR) activation, as rapamycin completely prevented nucleophosmin induction. Consistent with this finding, genetic ablation of Tsc1, a major upstream inhibitor of mTOR, resulted in nucleophosmin protein induction through increased translation of existing nucleophosmin mRNAs. Increases in nucleophosmin protein accumulation were suppressed by reintroduction of TSC1. Induction of nucleophosmin through Tsc1 loss resulted in a greater pool of actively translating ribosomes in the cytoplasm, higher overall rates of protein synthesis, and increased cell proliferation, all of which were dependent on efficient nucleophosmin nuclear export. Nucleophosmin protein accumulation in the absence of Tsc1 promoted the nuclear export of maturing ribosome subunits, providing a mechanistic link between TSC1/mTOR signaling, nucleophosmin-mediated nuclear export of ribosome subunits, protein synthesis levels, and cell growth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17308101      PMCID: PMC2859708          DOI: 10.1158/0008-5472.CAN-06-2875

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

Review 1.  The expanding TOR signaling network.

Authors:  Dietmar E Martin; Michael N Hall
Journal:  Curr Opin Cell Biol       Date:  2005-04       Impact factor: 8.382

2.  Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity.

Authors:  T Kondo; N Minamino; T Nagamura-Inoue; M Matsumoto; T Taniguchi; N Tanaka
Journal:  Oncogene       Date:  1997-09       Impact factor: 9.867

3.  Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability.

Authors:  S Hashemolhosseini; Y Nagamine; S J Morley; S Desrivières; L Mercep; S Ferrari
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

4.  Nucleophosmin is essential for ribosomal protein L5 nuclear export.

Authors:  Yue Yu; Leonard B Maggi; Suzanne N Brady; Anthony J Apicelli; Mu-Shui Dai; Hua Lu; Jason D Weber
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

5.  SHP-2 binds to Tyr763 and Tyr1009 in the PDGF beta-receptor and mediates PDGF-induced activation of the Ras/MAP kinase pathway and chemotaxis.

Authors:  L Rönnstrand; A K Arvidsson; A Kallin; C Rorsman; U Hellman; U Engström; C Wernstedt; C H Heldin
Journal:  Oncogene       Date:  1999-06-24       Impact factor: 9.867

6.  Down-regulation of nucleophosmin/B23 mRNA delays the entry of cells into mitosis.

Authors:  P S Jiang; B Y Yung
Journal:  Biochem Biophys Res Commun       Date:  1999-04-21       Impact factor: 3.575

Review 7.  The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb.

Authors:  Takahiro Nobukini; George Thomas
Journal:  Novartis Found Symp       Date:  2004

8.  Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.

Authors:  T Kamijo; F Zindy; M F Roussel; D E Quelle; J R Downing; R A Ashmun; G Grosveld; C J Sherr
Journal:  Cell       Date:  1997-11-28       Impact factor: 41.582

9.  Role of translocation in the activation and function of protein kinase B.

Authors:  M Andjelković; D R Alessi; R Meier; A Fernandez; N J Lamb; M Frech; P Cron; P Cohen; J M Lucocq; B A Hemmings
Journal:  J Biol Chem       Date:  1997-12-12       Impact factor: 5.157

Review 10.  Dysregulation of the TSC-mTOR pathway in human disease.

Authors:  Ken Inoki; Michael N Corradetti; Kun-Liang Guan
Journal:  Nat Genet       Date:  2005-01       Impact factor: 38.330

View more
  22 in total

1.  RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis.

Authors:  Anthony J Saporita; Hsiang-Chun Chang; Crystal L Winkeler; Anthony J Apicelli; Raleigh D Kladney; Jianbo Wang; R Reid Townsend; Loren S Michel; Jason D Weber
Journal:  Cancer Res       Date:  2011-09-21       Impact factor: 12.701

Review 2.  Deconvoluting mTOR biology.

Authors:  Jason D Weber; David H Gutmann
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

3.  Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas.

Authors:  Gwendoline Van Goietsenoven; Jenna Hutton; Jean-Paul Becker; Benjamin Lallemand; Francis Robert; Florence Lefranc; Christine Pirker; Guy Vandenbussche; Pierre Van Antwerpen; Antonio Evidente; Walter Berger; Martine Prévost; Jerry Pelletier; Robert Kiss; Terri Goss Kinzy; Alexander Kornienko; Véronique Mathieu
Journal:  FASEB J       Date:  2010-07-19       Impact factor: 5.191

4.  Hypergrowth mTORC1 signals translationally activate the ARF tumor suppressor checkpoint.

Authors:  Alexander P Miceli; Anthony J Saporita; Jason D Weber
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

5.  Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation.

Authors:  S N Brady; L B Maggi; C L Winkeler; E A Toso; A S Gwinn; C L Pelletier; J D Weber
Journal:  Oncogene       Date:  2009-06-29       Impact factor: 9.867

6.  Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome.

Authors:  Leonard B Maggi; Michael Kuchenruether; David Y A Dadey; Rachel M Schwope; Silvia Grisendi; R Reid Townsend; Pier Paolo Pandolfi; Jason D Weber
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

7.  mTOR transcriptionally and post-transcriptionally regulates Npm1 gene expression to contribute to enhanced proliferation in cells with Pten inactivation.

Authors:  Rafik Boudra; Rosyne Lagrafeuille; Corinne Lours-Calet; Cyrille de Joussineau; Gaëlle Loubeau-Legros; Cédric Chaveroux; Jean-Paul Saru; Silvère Baron; Laurent Morel; Claude Beaudoin
Journal:  Cell Cycle       Date:  2016-05-18       Impact factor: 4.534

Review 8.  Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis.

Authors:  Sharon S McDaniel; Michael Wong
Journal:  Neurosci Lett       Date:  2011-02-24       Impact factor: 3.046

9.  The determinants of head and neck cancer: Unmasking the PI3K pathway mutations.

Authors:  Fernanda S Giudice; Cristiane H Squarize
Journal:  J Carcinog Mutagen       Date:  2013-08-02

Review 10.  Using neurofibromatosis-1 to better understand and treat pediatric low-grade glioma.

Authors:  David H Gutmann
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.